Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

api image Lercanidipine-Hcl

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Lercanidipine Hcl Manufacturers in India Suppliers Lercanidipine Hcl Exporters Distributors Lercanidipine Hcl api active pharmaceuticals ingredients Lercanidipine Hcl manufacturers Side Effects bulk drugs raw material Lercanidipine Hcl companies Side Effects Importers Lercanidipine Hcl Lercanidipine Hcl Exporters Lercanidipine Hcl exporters FDA Lercanidipine Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Lercanidipine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Lercanidipine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Lercanidipine Hydrochloride active pharmaceutical ingredients Lercanidipine Hydrochloride committee active pharmaceutical ingredients manufacturer Lercanidipine Hydrochloride Active Pharmaceutical Ingredients manufacturer Lercanidipine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Lercanidipine Hcl, Lercanidipine Hcl manufacturer India, Lercanidipine Hcl product, Lercanidipine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Lercanidipine Hcl anti ulcer product, Certificate of Origin COA Lercanidipine Hcl COS Lercanidipine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Lercanidipine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Lercanidipine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Lercanidipine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Lercanidipine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Lercanidipine Hcl ingredients, api, HIV Lercanidipine Hcl, tablets, capsules, syrup & protein Lercanidipine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Lercanidipine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Lercanidipine Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image Lercanidipine Hcl
























 









 

 

 

HOME >> API >> API List 2 >> Lercanidipine Hcl >> Interaction

 Lercanidipine Hcl CAS Registry Number 132866-11-6

INTERACTION
Lercanidipine Hcl CAS Registry Number 132866-11-6

Calcium-channel blockers are a family of drugs used to treat angina, high blood pressure, heart arrhythmia, heart failure, and Raynaud’s disease, as well as to prevent migraine headaches.

Summary of Interactions with Vitamins, Herbs, and Foods
In some cases, an herb or supplement may appear in more than one category, which may seem contradictory. For clarification, read the full article for details about the summarized interactions.
Avoid Avoid: Adverse interaction—Avoid these supplements when taking this medication because taking them together may cause undesirable or dangerous results.

Pleurisy root
Depletion or interference

Interactions common to many, if not all, Calcium Channel Blockers are described in this article. Interactions reported for only one or several drugs in this class may not be listed in this article. Some drugs listed in this article are linked to articles specific to that respective drug; please refer to those individual drug articles. The information in this article may not necessarily apply to drugs in this class for which no separate article exists. If you are taking a Calcium Channel Blocker for which no separate article exists, talk with your doctor or pharmacist.

An asterisk next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

For interactions involving specific calcium-channel blocking drugs, refer to the highlighted medications listed below.

* Amlodipine
* Bepridil
* Diltiazem
* Felodipine
* Isradipine
* Nicardipine
* Nifedipine
* Nimodipine
* Nisoldipine
* Verapamil

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Lercanidipine

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.